114 related articles for article (PubMed ID: 30519799)
1. Metvan, bis(4,7-Dimethyl-1,10-phenanthroline)sulfatooxidovanadium(IV): DFT and Spectroscopic Study-Antitumor Action on Human Bone and Colorectal Cancer Cell Lines.
León IE; Ruiz MC; Franca CA; Parajón-Costa BS; Baran EJ
Biol Trace Elem Res; 2019 Sep; 191(1):81-87. PubMed ID: 30519799
[TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
3. A new oxidovanadium(IV) complex of oxodiacetic acid and dppz: spectroscopic and DFT study. Antitumor action on MG-63 human osteosarcoma cell line.
León IE; Parajón-Costa BS; Franca CA; Etcheverry SB; Baran EJ
Biol Trace Elem Res; 2015 Apr; 164(2):198-204. PubMed ID: 25534289
[TBL] [Abstract][Full Text] [Related]
4. Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity.
D'Cruz OJ; Uckun FM
Expert Opin Investig Drugs; 2002 Dec; 11(12):1829-36. PubMed ID: 12457442
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Activity Studies of Ruthenium(II) Complex Toward Human Osteosarcoma HOS Cells.
Zhu JW; Liu SH; Zhang GQ; Xu HH; Wang YX; Wu Y; Liu YM; Wang Y; Liang JB; Guo QF
J Membr Biol; 2016 Aug; 249(4):483-92. PubMed ID: 27007877
[TBL] [Abstract][Full Text] [Related]
6. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
7. Effect of Regiochemistry and Methylation on the Anticancer Activity of a Ferrocene-Containing Organometallic Nucleoside Analogue.
Ismail MK; Khan Z; Rana M; Horswell SL; Male L; Nguyen HV; Perotti A; Romero-Canelón I; Wilkinson EA; Hodges NJ; Tucker JHR
Chembiochem; 2020 Sep; 21(17):2487-2494. PubMed ID: 32255248
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Anti-Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells.
Benarous K; Serseg T; Mermer A; Tahmasebifar A; Boulebd H; Linani A
Chem Biodivers; 2024 May; 21(5):e202301833. PubMed ID: 38456582
[TBL] [Abstract][Full Text] [Related]
9. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity.
Narla RK; Dong Y; Klis D; Uckun FM
Clin Cancer Res; 2001 Apr; 7(4):1094-101. PubMed ID: 11309362
[TBL] [Abstract][Full Text] [Related]
10. Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.
Cadavid-Vargas JF; Leon IE; Etcheverry SB; Santi E; Torre MH; Di Virgilio AL
Anticancer Agents Med Chem; 2017; 17(3):424-433. PubMed ID: 27173967
[TBL] [Abstract][Full Text] [Related]
11. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
12. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of zoledronic acid against human osteosarcoma cells.
Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
[TBL] [Abstract][Full Text] [Related]
14. Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
Sanna D; Ugone V; Micera G; Buglyó P; Bíró L; Garribba E
Dalton Trans; 2017 Jul; 46(28):8950-8967. PubMed ID: 28640312
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.
León IE; Díez P; Etcheverry SB; Fuentes M
Metallomics; 2016 Aug; 8(8):739-49. PubMed ID: 27175625
[TBL] [Abstract][Full Text] [Related]
16.
Balsa LM; Quispe P; Baran EJ; Lavecchia MJ; León IE
Metallomics; 2020 Dec; 12(12):1931-1940. PubMed ID: 33107537
[TBL] [Abstract][Full Text] [Related]
17. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
Rathore K; Cekanova M
Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
[TBL] [Abstract][Full Text] [Related]
18. RAPTA-Decorated Polyacrylamide Nanoparticles: Exploring their Synthesis, Physical Properties and Effect on Cell Viability.
Sandland J; Savoie H; Boyle RW; Murray BS
Chembiochem; 2021 Mar; 22(5):931-936. PubMed ID: 33095468
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
20. Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.
Kubista B; Schoefl T; Mayr L; van Schoonhoven S; Heffeter P; Windhager R; Keppler BK; Berger W
J Exp Clin Cancer Res; 2017 Apr; 36(1):52. PubMed ID: 28403890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]